CAR-TCR Summit Series

CAR-TCR Summit Series

Biotechnology Research

Engineering a Disease Free World

About us

The CAR-TCR Summit Series is committed to delivering an exclusive platform to unite the community and explore the key challenges to your industry, guided by global thought leaders in each discipline. Dedicated to the development of safe, clinically effective and globally accessible therapies, the series is an unrivalled opportunity to gather with experts in your discipline. From next-generation development to supply chain and logistics, and exploring challenges specific to each area, we create these forums to deliver value and in-depth learnings across the development pipeline, on a global stage.

Website
https://ter.li/04sziw
Industry
Biotechnology Research
Company size
501-1,000 employees

Updates

  • 𝗪𝗵𝗼 𝗪𝗶𝗹𝗹 𝗬𝗼𝘂 𝗠𝗲𝗲𝘁? Excited for the 8th CAR-TCR Summit Europe! 🌟 This is your chance to connect with industry leaders driving breakthroughs in cellular therapies. Meet experts from: 🔹 𝗖𝗮𝗯𝗮𝗹𝗲𝘁𝘁𝗮 𝗕𝗶𝗼 – Tackling safety concerns in autoimmune indications and selecting the right diseases for optimal efficacy. 🔹 𝗦𝗮𝗻𝗮 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 – Improving regulatory engagement and tailoring guidelines for faster approval. 🔹 𝗧-𝗸𝗻𝗶𝗳𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 – Leveraging gene editing and armouring to enhance durability and persistence. 🔹 𝗘𝗹𝗶 𝗟𝗶𝗹𝗹𝘆 – Advancing manufacturing processes to improve robustness and fine-tune cell therapy conditions. 🔹 𝗞𝗶𝘁𝗲, 𝗔 𝗚𝗶𝗹𝗲𝗮𝗱 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 – Using multiple tumour models to improve patient selection and clinical trial success. Connect with 𝗸𝗲𝘆 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝗶𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝘆, 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗯𝗶𝗼𝗹𝗼𝗴𝘆, and 𝗖𝗠𝗖 to advance the manufacturability, quality control, and engineering of complex cell therapies. Don’t miss out on the opportunity to learn, network, and collaborate with the brightest minds in the field! 🔗 Register Today - https://ter.li/ahysp3 🔗 View the Agenda - https://ter.li/5rmzte #CAR_TCR #CellTherapy #Biotech #Innovation #Summit #CellTherapy #CART #TCR #Biopharma #ClinicalDevelopment #Manufacturing #Networking #IndustryLeadership

    • Promotional graphic for the 8th Annual CAR-TCR Summit Europe, highlighting event dates from February 25-27, 2025, in London, UK. The image features silhouettes of two individuals with a background of the London cityscape at sunset. A pie chart displays attendee demographics with percentages for various professional titles.
  • Need another reason to join us at 𝗧𝗵𝗲 𝟴𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗔𝗥-𝗧𝗖𝗥 𝗦𝘂𝗺𝗺𝗶𝘁 𝗘𝘂𝗿𝗼𝗽𝗲? Hear first-hand from our previous attendees and speakers about the ground-breaking insights, innovative solutions, and valuable networking opportunities that make this event a must-attend for anyone in the CAR-T and TCR space. 𝗦𝘁𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝗰𝗼𝗻𝘃𝗶𝗻𝗰𝗶𝗻𝗴? Check out the full event guide here: https://ter.li/e1aavj Register & Save up to $700 here: https://ter.li/ahysp3 Don’t miss out on the chance to be part of the future of cell therapy!

    • Need another reason to join us at 𝗧𝗵𝗲 𝟴𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗔𝗥-𝗧𝗖𝗥 𝗦𝘂𝗺𝗺𝗶𝘁 𝗘𝘂𝗿𝗼𝗽𝗲?

Hear first-hand from our previous attendees and speakers about the ground-breaking insights, innovative solutions, and valuable networking opportunities that make this event a must-attend for anyone in the CAR-T and TCR space. 

𝗦𝘁𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝗰𝗼𝗻𝘃𝗶𝗻𝗰𝗶𝗻𝗴? 
Check out the full event guide here: https://ter.li/e1aavj
Register & Save up to $700 here: https://ter.li/ahysp3

Don’t miss out on the chance to be part of the future of cell therapy!
  • Have you checked out the agenda for the 8th CAR-TCR Summit Europe yet? 📊 Here’s Your Content Breakdown: 🧬 𝟲𝟬% 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆: Explore the latest innovations and strategies for tackling solid and liquid tumours 🔬 𝟮𝟬% 𝗔𝘂𝘁𝗼𝗶𝗺𝗺𝘂𝗻𝗲: Spotlighting navigating safety concerns, improving durability of response, and choosing disease targets 💰 𝟭𝟬% 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁: Insights from successful IPOs to better understand ways to secure increased investment 🌐 𝟭𝟬% 𝗙𝗶𝗲𝗹𝗱 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Emerging trends and future directions for CAR-T and TCR Must-Attend Sessions: 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 𝘚𝘱𝘰𝘵𝘭𝘪𝘨𝘩𝘵 • Development of Effective TIL Therapy for Solid Tumours - George Coukos, University of Lausanne • Redesigning CAR Structure to Bridge the Gap & Access Solid Tumours - Laurent Poirot, Cellectis • Gene-Edited, Multi-Armoured TCR-T Cells for Improved Durability & Persistence - Peggy Sotiropoulou, T-knife Therapeutics 𝘈𝘶𝘵𝘰𝘪𝘮𝘮𝘶𝘯𝘦 𝘚𝘱𝘰𝘵𝘭𝘪𝘨𝘩𝘵 • Development Progress & Opportunities for CAR-T in Autoimmune Disease - Gwen Binder, Cabaletta Bio • Developing TCR & CAR Targeted Engineered Treg Cells for Autoimmune Diseases - Tiffany Chen, GentiBio Join us to drive success in clinical trials, secure regulatory approvals and ultimately position cell therapy as the first line treatment for oncological and non-oncological indications. 🌐 Learn More: https://ter.li/nai82g

    • No alternative text description for this image
  • 🚀 The Cell Therapy Field is Evolving: Here's Why You Should Be Excited! 🚀 After a challenging few years, the cell therapy industry is now seeing new promise with significant news, approvals such as Autolus Therapeutics and investments like Arsenal Biosciences, Inc. There's a lot to be excited about as the field advances! 🌱 The 𝟴𝘁𝗵 𝗖𝗔𝗥-𝗧𝗖𝗥 𝗦𝘂𝗺𝗺𝗶𝘁 𝗘𝘂𝗿𝗼𝗽𝗲 is returning to London (February 25-27), and it’s the perfect opportunity to unite with key opinion leaders and industry executives across pharma and biotech, working in autologous, allogeneic, in vivo cell therapies, and more.! Here are some of the recent trends in the cell therapy landscape: • 𝗔𝗿𝗺𝗼𝘂𝗿𝗶𝗻𝗴 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀: Innovations like gene editing, cytokine engineering, and enzymatic armouring are paving the way for safer, more precise treatments with improved patient outcomes. 🔬 • 𝗖𝗔𝗥 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗜𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: The decision of which disease indications to target remains a strategic challenge, but with many companies now expanding into autoimmune indications, we’re seeing significant progress beyond oncology. 🎯 Don’t miss out on this opportunity to be part of a transformative event in cell therapy! View the Event Guide: https://ter.li/hl61c1 *Data provided by Beacon*

    • Promotional image for the 8th Annual Europe CAR-TCR Summit in London, featuring an iconic silhouette of the London Eye against a vivid red backdrop. Event dates are 25th-27th February, 2025.
  • Your European hub of next generation cell therapy innovation is coming to London February 2025! The 8th CAR-TCR Summit is your must attend forum to remain on the pulse of recent innovation in cell therapy. Join us to collaborate, innovate, and overcome the shared challenges of safety concerns, high cost of goods, effective tumour targeting, and more. Let’s work together to drive success in clinical trials, secure regulatory approvals, and position cell therapy as the first-line treatment for oncological and non-oncological indications. The best part is this week is our biggest early bird week and is your best chance to maximise savings on your pass. What are you waiting for? Register now! Full Brochure- https://ter.li/vdamnd Register- https://ter.li/02e7in

    • No alternative text description for this image

Affiliated pages

Similar pages